Acute chest syndrome
MONDO:0005632A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia.
Also known as: ACS
30 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
Simple breathing device may speed recovery from a deadly sickle cell complication
Disease control Not yet recruitingThis trial investigates whether continuous positive airway pressure (CPAP) can help adults with sickle cell disease recover faster from acute chest syndrome, a serious lung complication. Participants who need extra oxygen are randomly assigned to receive either standard oxygen al…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Heart attack without blockage: trial tests gentler blood thinners for SCAD
Disease control Not yet recruitingThis trial tests whether a less intensive antiplatelet therapy is safer and as effective as standard dual therapy for people with spontaneous coronary artery dissection (SCAD), a rare cause of heart attack in women aged 30–55. Unlike typical heart attacks, SCAD involves a tear in…
Phase 4 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Heart attack survivors may get Anti-Inflammatory boost from diabetes drug
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug typically used for diabetes, can lower inflammation in the heart arteries of people who recently had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or …
Phase 4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gut bacteria fix may boost heart drug power
Disease control Not yet recruitingThis study tests whether a short course of the antibiotic rifaximin can improve how well the blood thinner ticagrelor works in people who have had a heart attack. The idea is that unhealthy gut bacteria may interfere with the drug, and clearing them out could help prevent future …
Phase 4 • Sponsor: Collegium Medicum w Bydgoszczy • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a bedside ultrasound predict a deadly sickle cell complication?
Diagnosis Not yet recruitingThis study tests whether a bedside lung ultrasound, done within six hours of arriving at the emergency department, can help diagnose acute chest syndrome in adults with sickle cell disease experiencing a vaso-occlusive crisis. Acute chest syndrome is a serious lung complication t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
New ultrasound tool could spare heart attack patients a second procedure
Diagnosis Not yet recruitingThis study is testing a new tool called UFR, which uses ultrasound images to measure blockages in heart arteries during a heart attack. Currently, the most accurate method requires patients to return 30 days later for a second invasive procedure. The study will enroll 200 heart a…
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Could lying on your stomach ease a deadly sickle cell complication?
Symptom relief Not yet recruitingThis study tests whether awake prone positioning (lying on the stomach while awake) can help sickle cell patients with severe acute chest syndrome in the ICU. The approach aims to improve oxygen levels and breathing by evening out air flow in the lungs. Fifteen adults will be enr…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 13:15 UTC
-
Frailty may predict heart attack outcomes better than current tools
Knowledge-focused Not yet recruitingThis study will follow 645 older adults (65+) who come to the hospital with a heart attack. Researchers want to see if frailty—a state of reduced strength and energy—affects how doctors treat them and whether they have serious problems like death or another heart event within 30 …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC